UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gene therapy approaches to regenerating bone

Advanced drug delivery reviews, 2012-09, Vol.64 (12), p.1320-1330

2012

Volltextzugriff (PDF)

Matrix stiffness determines the fate of nucleus pulposus–derived stem cells

Biomaterials, 2015-05, Vol.49, p.68-76

2015

Volltextzugriff (PDF)

Smad8/BMP2-engineered mesenchymal stem cells induce accelerated recovery of the biomechanical properties of the achilles tendon

Journal of orthopaedic research, 2012-12, Vol.30 (12), p.1932-1939

2012

Volltextzugriff (PDF)

Adeno-associated virus-coated allografts: a novel approach for cranioplasty

Journal of tissue engineering and regenerative medicine, 2012-11, Vol.6 (10), p.e43-e50

2012

Volltextzugriff (PDF)

The effect of ex vivo dynamic loading on the osteogenic differentiation of genetically engineered mesenchymal stem cell model

Journal of tissue engineering and regenerative medicine, 2011-05, Vol.5 (5), p.384-393

2011

Volltextzugriff (PDF)

Oral Administration of a Novel Small Molecule Blocks the BMP Canonical and the Non-canonical BMP2, BMP4, and BMP5 Signaling Pathways Ameliorates EAE Through Oligodendrogenesis Remyelination and Preservation of Axonal Integrity and Reduces Astrogenesis (P7-6.015)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Specific Blockade of Bone Morphogenetic Protein-2/4 induces Oligodendrogenesis and Remyelination in Demyelinating Disorders (2042)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders

Neurotherapeutics, 2021-07, Vol.18 (3), p.1798-1814

2021

Volltextzugriff (PDF)

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Primary Progressive Multiple Sclerosis: Safety and Efficacy Snapshot (P7-4.001)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with Primary Progressive Multiple Sclerosis: safety and efficacy snapshot (1911)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Five Years Analysis of anti-Glatiramer Acetate (GA) Antibodies in Patients with Relapsing Remitting Multiple Sclerosis Treated with GA Depot (P5-4.010)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Molecular targets for tendon neoformation

The Journal of clinical investigation, 2008-02, Vol.118 (2), p.439-444

2008

Volltextzugriff (PDF)

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with primary progressive multiple sclerosis: safety and efficacy snapshot (1956)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Targeted Gene-and-host Progenitor Cell Therapy for Nonunion Bone Fracture Repair

Molecular therapy, 2011-01, Vol.19 (1), p.53-59

2011

Volltextzugriff (PDF)

Gene-Modified Adult Stem Cells Regenerate Vertebral Bone Defect in a Rat Model

Molecular pharmaceutics, 2011-10, Vol.8 (5), p.1592-1601

2011

Volltextzugriff (PDF)

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (No Evidence of Disease Activity) subpopulation three-years analysis (1936)

Neurology, 2020-04, Vol.94 (15_supplement)

2020

Volltextzugriff (PDF)

Peptide-Modified “Smart” Hydrogels and Genetically Engineered Stem Cells for Skeletal Tissue Engineering

Biomacromolecules, 2010-06, Vol.11 (6), p.1516-1526

2010

Volltextzugriff (PDF)

Pre-Clinical Studies and Evaluation of Treatment Need of Glatiramer Acetate Depot (Long Acting Injection) (P5.314)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Relapsing Remitting Multiple Sclerosis: Safety, Tolerability and Efficacy (No Evidence of Disease Activity) Two-Years Analysis (P3.2-052)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo

Biomaterials, 2009-09, Vol.30 (27), p.4639-4648

2009

Volltextzugriff (PDF)

Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.359)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Gene therapy approaches to regenerating bone: TARGETED DELIVERY OF THERAPEUTICS TO BONE AND CONNECTIVE TISSUES

Advanced drug delivery reviews, 2012, Vol.64 (12), p.1320-1330

2012

Volltextzugriff (PDF)

Adeno-associated virus-coated allografts: a novel approach for cranioplasty: Adeno-associated virus-coated allografts for cranioplasty

Journal of tissue engineering and regenerative medicine, 2012-11, Vol.6 (10), p.e43-e50

2012

Volltextzugriff (PDF)

Real-time bioluminescence functional imaging for monitoring tissue formation and regeneration

Methods in molecular biology (Clifton, N.J.), 2013, Vol.1048, p.181

2013

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(23)
Buchkapitel
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Animals
(12)
Science & Technology
(12)
Life Sciences & Biomedicine
(10)
Mice
(8)
Tissue Engineering - Methods
(5)
Bone Morphogenetic Protein 2 - Metabolism
(4)
Bone Regeneration
(4)
Engineering
(4)
Engineering, Biomedical
(4)
Female
(4)
Humans
(4)
Mesenchymal Stromal Cells - Cytology
(4)
Technology
(4)
Tissue Engineering
(4)
Biotechnology & Applied Microbiology
(3)
Bone And Bones - Metabolism
(3)
Cell Biology
(3)
Dentistry
(3)
Gene Transfer Techniques
(3)
Medicine, Research & Experimental
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gene therapy approaches to regenerating bone

Matrix stiffness determines the fate of nucleus pulposus–derived stem cells

Smad8/BMP2-engineered mesenchymal stem cells induce accelerated recovery of the biomechanical properties of the achilles tendon

Adeno-associated virus-coated allografts: a novel approach for cranioplasty

The effect of ex vivo dynamic loading on the osteogenic differentiation of genetically engineered mesenchymal stem cell model

Oral Administration of a Novel Small Molecule Blocks the BMP Canonical and the Non-canonical BMP2, BMP4, and BMP5 Signaling Pathways Ameliorates EAE Through Oligodendrogenesis Remyelination and Preservation of Axonal Integrity and Reduces Astrogenesis (P7-6.015)

Specific Blockade of Bone Morphogenetic Protein-2/4 induces Oligodendrogenesis and Remyelination in Demyelinating Disorders (2042)

Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Primary Progressive Multiple Sclerosis: Safety and Efficacy Snapshot (P7-4.001)

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with Primary Progressive Multiple Sclerosis: safety and efficacy snapshot (1911)

Five Years Analysis of anti-Glatiramer Acetate (GA) Antibodies in Patients with Relapsing Remitting Multiple Sclerosis Treated with GA Depot (P5-4.010)

Molecular targets for tendon neoformation

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with primary progressive multiple sclerosis: safety and efficacy snapshot (1956)

Targeted Gene-and-host Progenitor Cell Therapy for Nonunion Bone Fracture Repair

Gene-Modified Adult Stem Cells Regenerate Vertebral Bone Defect in a Rat Model

Glatiramer Acetate Depot (extended-release) phase IIa study in patients with relapsing remitting multiple sclerosis: safety, tolerability and efficacy (No Evidence of Disease Activity) subpopulation three-years analysis (1936)

Peptide-Modified “Smart” Hydrogels and Genetically Engineered Stem Cells for Skeletal Tissue Engineering

Pre-Clinical Studies and Evaluation of Treatment Need of Glatiramer Acetate Depot (Long Acting Injection) (P5.314)

Glatiramer Acetate Depot (Extended-Release) Phase IIa Study in Patients with Relapsing Remitting Multiple Sclerosis: Safety, Tolerability and Efficacy (No Evidence of Disease Activity) Two-Years Analysis (P3.2-052)

The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo

Glatiramer Acetate Depot (extended-release) Phase IIa one-year study in patients with Relapsing-remitting Multiple Sclerosis: Safety, tolerability and efficacy – NEDA Analysis (P6.359)

Gene therapy approaches to regenerating bone: TARGETED DELIVERY OF THERAPEUTICS TO BONE AND CONNECTIVE TISSUES

Adeno-associated virus-coated allografts: a novel approach for cranioplasty: Adeno-associated virus-coated allografts for cranioplasty

Real-time bioluminescence functional imaging for monitoring tissue formation and regeneration

Suchergebnisse filtern